Return On Assets in % of NovoCure Ltd from Q2 2016 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
NovoCure Ltd quarterly/annual Return On Assets history and change rate from Q2 2016 to Q3 2025.
  • NovoCure Ltd Return On Assets for the quarter ending 30 Sep 2025 was -13.9 %, a 9.42% decline year-over-year.
  • NovoCure Ltd annual Return On Assets for 2024 was -14.1 %, a 21.4% increase from 2023.
  • NovoCure Ltd annual Return On Assets for 2023 was -17.9 %, a 126% decline from 2022.
  • NovoCure Ltd annual Return On Assets for 2022 was -7.91 %, a 50% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

NovoCure Ltd Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -13.9 -1.2 -9.42% 01 Jul 2025 30 Sep 2025
Q2 2025 -13.8 +0.79 +5.42% 01 Apr 2025 30 Jun 2025
Q1 2025 -13.3 +3.52 +20.9% 01 Jan 2025 31 Mar 2025
Q4 2024 -14.1 +3.84 +21.4% 01 Oct 2024 31 Dec 2024
Q3 2024 -12.7 +4.15 +24.6% 01 Jul 2024 30 Sep 2024
Q2 2024 -14.6 +0.25 +1.68% 01 Apr 2024 30 Jun 2024
Q1 2024 -16.9 -4.87 -40.6% 01 Jan 2024 31 Mar 2024
Q4 2023 -17.9 -9.99 -126% 01 Oct 2023 31 Dec 2023
Q3 2023 -16.9 -9.83 -139% 01 Jul 2023 30 Sep 2023
Q2 2023 -14.8 -8.87 -149% 01 Apr 2023 30 Jun 2023
Q1 2023 -12 -6.76 -129% 01 Jan 2023 31 Mar 2023
Q4 2022 -7.91 -2.64 -50% 01 Oct 2022 31 Dec 2022
Q3 2022 -7.06 -4.57 -184% 01 Jul 2022 30 Sep 2022
Q2 2022 -5.97 -5.47 -1092% 01 Apr 2022 30 Jun 2022
Q1 2022 -5.22 -6.75 -443% 01 Jan 2022 31 Mar 2022
Q4 2021 -5.28 -8.43 -268% 01 Oct 2021 31 Dec 2021
Q3 2021 -2.49 -6.43 -163% 01 Jul 2021 30 Sep 2021
Q2 2021 -0.5 -2.92 -121% 01 Apr 2021 30 Jun 2021
Q1 2021 1.52 -0.41 -21.2% 01 Jan 2021 31 Mar 2021
Q4 2020 3.15 +4.85 01 Oct 2020 31 Dec 2020
Q3 2020 3.94 +10.9 01 Jul 2020 30 Sep 2020
Q2 2020 2.41 +13.8 01 Apr 2020 30 Jun 2020
Q1 2020 1.94 +18.4 01 Jan 2020 31 Mar 2020
Q4 2019 -1.7 +18.3 +91.5% 01 Oct 2019 31 Dec 2019
Q3 2019 -6.95 +12.8 +64.8% 01 Jul 2019 30 Sep 2019
Q2 2019 -11.4 +9.19 +44.7% 01 Apr 2019 30 Jun 2019
Q1 2019 -16.5 +7.18 +30.4% 01 Jan 2019 31 Mar 2019
Q4 2018 -20 +3.47 +14.8% 01 Oct 2018 31 Dec 2018
Q3 2018 -19.7 +7.63 +27.9% 01 Jul 2018 30 Sep 2018
Q2 2018 -20.6 +14.1 +40.7% 01 Apr 2018 30 Jun 2018
Q1 2018 -23.7 +18.4 +43.8% 01 Jan 2018 31 Mar 2018
Q4 2017 -23.5 +24.3 +50.9% 01 Oct 2017 31 Dec 2017
Q3 2017 -27.4 +23.2 +45.9% 01 Jul 2017 30 Sep 2017
Q2 2017 -34.7 +18.7 +35% 01 Apr 2017 30 Jun 2017
Q1 2017 -42.1 01 Jan 2017 31 Mar 2017
Q4 2016 -47.8 01 Oct 2016 31 Dec 2016
Q3 2016 -50.6 01 Jul 2016 30 Sep 2016
Q2 2016 -53.4 01 Apr 2016 30 Jun 2016

NovoCure Ltd Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -14.1 +3.84 +21.4% 01 Jan 2024 31 Dec 2024
2023 -17.9 -9.99 -126% 01 Jan 2023 31 Dec 2023
2022 -7.91 -2.64 -50% 01 Jan 2022 31 Dec 2022
2021 -5.28 -8.43 -268% 01 Jan 2021 31 Dec 2021
2020 3.15 +4.85 01 Jan 2020 31 Dec 2020
2019 -1.7 +18.3 +91.5% 01 Jan 2019 31 Dec 2019
2018 -20 +3.47 +14.8% 01 Jan 2018 31 Dec 2018
2017 -23.5 +24.3 +50.9% 01 Jan 2017 31 Dec 2017
2016 -47.8 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.